top of page
INVESTMENT CORNER
This list is not exhaustive and should serve as a starting point for companies searching for funding
Type of Investor/Fund | Field of Investment/Funding | Geographic focus | Stage of Investment/Funding | Preferred Ticket Size | |
---|---|---|---|---|---|
3B Future Health Fund | Venture Capital Fund | BioTech Therapeutics | Europe, Israel, US | Later stage (Series A+) | 2m - 7m |
AbbVie Ventures | Corporate Investor (CVC) | Therapeutics | US and Europe | Early stage (Preseed - Seed) Later stage (Series A+) | |
Abingworth | Venture Capital Fund | BioTech Therapeutics Hightech, Technology Platforms | US & Europe | Later stage (Series A+) | 15m-30m |
Adbio partners | Venture Capital Fund | innovative early-stage startups in life sciences | Europe | Early stage (Preseed - Seed) | |
Almeda Ventures | Venture Capital Fund | MedTech Digital Health | Global | ||
Andera Partners (Andera Life Sciences) | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Software, Digitalisation | US & Europe | Early stage (Preseed - Seed) Later stage (Series A+) Private Equity | 5m-35m |
AngelInvest Ventures | Business Angel | MedTech Diagnostics Digital Health Hightech, Technology Platforms Software, Digitalisation | EU | Early stage (Preseed - Seed)
| 100k |
Angels4Health
| Business Angel | BioTech MedTech Diagnostics Therapeutics Digital Health | DACH | Early stage (Preseed - Seed)
| |
Apollo Health Ventures
| Venture Capital Fund | BioTech Therapeutics Hightech, Technology Platforms Ageing angle | Europe, USA | Early stage (Preseed - Seed)
Later stage (Series A+)
Private Equity | |
Arix Bioscience | Venture Capital Fund | BioTech Therapeutics Novel therapeutics with first or best in class approach | Global | Early stage (Preseed - Seed)
Later stage (Series A+)
| |
Arve Capital Gmbh | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Software, Digitalisation | Europe, Israel | Early stage (Preseed - Seed) Later stage (Series A+) | 300k-500k to 1m |
BMBF: DATIpilot – Fördern und Lernen für Innovation und Transfer: Ein Experimentierraum im Umfeld der DATI | Research Grant/Funding | Germany | |||
BMBF: Forschungzulage
| Other | Germany | |||
BMBF: Funding for Horizon Europe application preparation (BMBF) | Research Grant/Funding | Germany | up to 50k | ||
BMBF: KMU-innovativ: Biomedizin | Research Grant/Funding | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation < 1000 FTE, < 100m turnover | Germany | funding amount not specified (covering max. 50% of costs) | |
BMBF: Modellierung der Ausbreitung von Infektionskrankheiten | Research Grant/Funding | Hightech, Technology Platforms Software, Digitalisation | Germany | grant | |
BMBF: Multidisziplinaere Projekte zur personalisierten Medizin | Research Grant/Funding | Therapeutics Digital Health Software, Digitalisation | Germany | grant | |
BMBF: Neue Produkte fuer die Bioeakonomie | Research Grant/Funding | BioTech Hightech, Technology Platforms | Germany | grant up to 65k in initial phase | |
BMBF: START-interactive | Research Grant/Funding | Digital Health Software, Digitalisation | Germany | Early stage (Preseed - Seed)
| up to 400k (covering 80%) |
BMBF: VIP+ - Validierungsfoerderung | Research Grant/Funding | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Germany | grant up to 1.5m | |
BMFi: Zukunftsfonds | Research Grant/Funding | no direct investments | |||
BMWi: INVEST (BAFA) | Other | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation all sectors | Germany | Early stage (Preseed - Seed)
| 25% subsidy for private investors acquiring shares; minimum investment 10k, maximum subsidy per investment per person 200k |
BMWi: Mikromezzaninfonds Deutschland | Other | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation loan, all sectors | loan up to 50k | ||
BMWi: ZIM (Zentrales Innovationsprogramm Mittelstand) | Research Grant/Funding | for research projects | Germany | grant up to 550k | |
BMWi: go-Digital | Research Grant/Funding | Germany | up to 20k | ||
BMWi: go-Inno | Research Grant/Funding | Germany | up to 20k | ||
BW: Beteiligungsfonds Baden-Wuerttemberg | Institutional Investor | aid for companies in crisis | Baden-Wuerttemberg | min. 800k | |
BW: EXI-Gruendungsgutscheine | Other | Baden-Wuerttemberg | |||
BW: Innovationsgutschein A und B des Landes | Research Grant/Funding | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation all sectors, < 100 FTE, < 20M turnover | Baden-Wuerttemberg | Voucher A: 2.5k Voucher B: 5k | |
BW: Innovationsgutscheine BW | Research Grant/Funding | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation all sectors, <5 years, <100 FTE, <20M turnover | Baden-Wuerttemberg | up to 20K (covering max. 50%) | |
BW: Invest BW - Foerderung von Innovations- und Technologievorhaben | Research Grant/Funding | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation all sectors, concrete R&D project | Baden-Wuerttemberg | 20k-1m (up to 3m for consortia) covering 45%-15% of total costs depending on company size | |
BW: Junge Innovatoren | Research Grant/Funding | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation all sectors, academic institutes | Baden-Wuerttemberg | Early stage (Preseed - Seed)
| 50% of salary for up to 3 persons; additional funding up to 25k for coaching and materials |
BW: Life Science Accelerator Baden-Wuerttemberg | Start-up Accelerator | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms coaching/mentoring program | Baden-Wuerttemberg | ||
BW: Startup BW Pre-Seed | Other | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation all sectors, <5 years | Baden-Wuerttemberg | Early stage (Preseed - Seed)
| up to 400k (80% |
BaseLaunch (CH) | Start-up Accelerator | BioTech Therapeutics Hightech, Technology Platforms | Early stage (Preseed - Seed)
| up to 500k convertile loan | |
BayBG Venture Capital | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Focus on Bavaria | Early stage (Preseed - Seed)
Later stage (Series A+)
| up to 5m |
Bayern Kapital | Institutional Investor | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Bavaria | Early stage (Preseed - Seed)
Later stage (Series A+)
Private Equity | 0.25m-25m |
BioGeneration Ventures | Venture Capital Fund | BioTech MedTech Therapeutics Hightech, Technology Platforms | Early stage (Preseed - Seed) | ||
BioMed Partners | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Hightech, Technology Platforms | EU, Switzerland | Early stage (Preseed - Seed)
Later stage (Series A+)
| |
Bioqube Ventures | Venture Capital Fund | BioTech Therapeutics Hightech, Technology Platforms | EU | Early stage (Preseed - Seed)
Later stage (Series A+)
| 3m-6m |
Blue Fund Consulting & Invest GmbH
| Business Angel | Hightech, Technology Platforms Software, Digitalisation | |||
Blue Ribbon Partners | Start-up Accelerator | commercialisation support | |||
Boehringer Ingelheim Venture Fund | Corporate Investor (CVC) | BioTech Therapeutics Digital Health | Global, but focus on North America, EU, Israel | Early stage (Preseed - Seed)
| up to 3m |
Born2grow Seedfonds (part of Zukunftsfonds Heilbronn) | Family Office/Private Investor | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Global | Early stage (Preseed - Seed)
Later stage (Series A+)
| 0.5m-1m pre-seed, 2m-5m follow-on |
Brandon Capital | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics | Early stage (Preseed - Seed) Later Stage (Series A+) | ||
Bundesverband Deutsche Startups e.V
| Other | ||||
Business Angels Connect
| Business Angel | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation It is an association of different investors, therefore each investor has izts focus. | EU (focus EU?) | Early stage (Preseed - Seed)
| mostly 100k-500k |
Business Angels Frankfurt Rhein-Main
| Business Angel | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Frankfurt region | Early stage (Preseed - Seed)
| |
Business Angels Region Stuttgart e.V. | Business Angel | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Stuttgart region | Early stage (Preseed - Seed)
| 0.25m-1m |
Business Angels Start-up Region Ostwuerttemberg | Business Angel | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Eastern Baden-Wuerttemberg | Early stage (Preseed - Seed)
| |
CAPNAMIC Ventures | Venture Capital Fund | Digital Health Hightech, Technology Platforms Software, Digitalisation | DACH | Early stage (Preseed - Seed)
| |
COI Partners | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | DACH | Early stage (Preseed - Seed)
| |
CVC Capital Partners
| Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Global |
Private Equity | |
Caixa Capital Risc | Venture Capital Fund | Therapeutics Digital Health | Europe, US, Canada | Early stage (Preseed - Seed) Later stage (Series A+) | 0.5m - 4m |
Carma Fund | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms | Germany (60%) | Early stage (Preseed - Seed)
| |
Companisto | Business Angel | Digital Health Hightech, Technology Platforms Software, Digitalisation | DACH | Early stage (Preseed - Seed)
Later stage (Series A+)
| 0.5m-2.5m |
Coparion | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation invest in all technological sectors (with the exception of those defined according to EIB�s principles and standards as �EIB excluded activities�) | Germany | Early stage (Preseed - Seed)
| 0.5m-8m (max 15m) |
Creathor Venture | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation Focus Healt: 1. DigHealth 2. Diagnosis 3. Devices 4. Drug dev. Focus Tech: 1. Machine Intelligence 2. Industry 4.0 | DACH | Early stage (Preseed - Seed)
Later stage (Series A+)
| 0.5m-2.5m |
Cultivation Capital | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Early stage (Preseed - Seed) | 100k – 3.5m | |
DB Digital Ventures | Corporate Investor (CVC) | Digital Health Hightech, Technology Platforms Software, Digitalisation Digital twins, sensors, 3D printing, robotic | Global | Early stage (Preseed - Seed)
Later stage (Series A+)
| 1-4m |
DeepScienceVentures (DSV) | Other | BioTech Therapeutics Hightech, Technology Platforms build companies based on analysis | |||
DeepTech & Climate Fonds | Venture Capital Fund | BioTech Digital Health Hightech, Technology Platforms | Europe | Early stage (Preseed - Seed)
Later stage (Series A+)
| 1m-30m (as anchor investor, private matching needed) |
Deepbridge Capital | Venture Capital Fund | ||||
Deutsche Boerse Venture Network
| Other | ||||
Dieter von Holtzbrink Ventures
| Venture Capital Fund | Digital Health Software, Digitalisation Digital Tech Fund: deep tech and education startups | Early stage (Preseed - Seed)
| 0.5m-2m | |
Digital Health Innovation programme | Start-up Accelerator | Digital Health | |||
Droia Ventures | Venture Capital Fund | Therapeutics therapeutics for oncology and genetic disease | Global | Early stage (Preseed - Seed)
Later stage (Series A+)
| |
EMBL Ventures | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Hightech, Technology Platforms | Early stage (Preseed - Seed)
| ||
EQT Life Sciences | Venture Capital Fund | BioTech MedTech Therapeutics Digital Health | Global but 2/3 of the fund must be invested in EU |
Later stage (Series A+)
| 10-60M |
EU: EIC Accelerator | Research Grant/Funding | EU and associated countries | grants up to 2.5m for innovation development costs,
investments (direct equity investments) up to 15m | ||
EU: EIC Pathfinder | Research Grant/Funding | EU and associated countries | grants up to 4m | ||
EU: EIC Transition | Research Grant/Funding | EU and associated countries | Grants up to 2.5m | ||
EU: EIT Health Catapult (EU) | Start-up Accelerator | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | EU and associated countries | up to 40k cash prize | |
EU: Eurostars | Research Grant/Funding | EU and associated countries | up to 0.5m (in Germany) | ||
EU: Horizon Europe | Research Grant/Funding | diverse | EU and associated countries | up to several m | |
Earlybird Venture Capital
| Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation VISION LAB: accelerator for migrant entrepreneurs (workshops, mentoring and pre-seed 25K) | Europe | up to 10m | |
Elaia Partners | Venture Capital Fund | BioTech MedTech Diagnostics Digital Health Hightech, Technology Platforms Software, Digitalisation | Global (focus Europe, Israel) | Early stage (Preseed - Seed)
Later stage (Series A+)
| 0.3m-15m |
Eppendorf Epic | Corporate Investor (CVC) | BioTech MedTech Diagnostics Hightech, Technology Platforms | Europe, US, Canada | Early stage (Preseed - Seed) Later stage (Series A+) | up to 10m |
Forbion | Venture Capital Fund | BioTech MedTech Diagnostics | Global | Early stage (Preseed - Seed)
Later stage (Series A+)
| |
Forty51 | Venture Capital Fund | BioTech Therapeutics preference for CNS, oncology, immunology and inflammation, fibrotic disorders and opthalmology | Europe | Early stage (Preseed - Seed)
| both |
FunderNation
| Other | MedTech Software, Digitalisation | Germany | ||
GEM | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation diverse | Global (focus Emerging Markets) | ||
Gateway Ventures
| Business Angel | BioTech MedTech Diagnostics Therapeutics Digital Health Software, Digitalisation | DACH | Early stage (Preseed - Seed)
| 0.3-1m |
German Startups Group VC
| Venture Capital Fund | Software, Digitalisation |
Later stage (Series A+)
| ||
Gilde Healthcare | Venture Capital Fund | BioTech Med Tech Therapeutics Digital Health | Europe, USA, Canada | Later Stage (Series A+) Private Equity | up to 50m |
Gimv | Venture Capital Fund | BioTech MedTech Therapeutics Software, Digitalisation diverse | Benelux, France, DACH |
Later stage (Series A+)
| 5m-75m |
Global Brain | Venture Capital Fund | BioTech Med Tech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Global | Later Stage (Series A+) | 1-3m first investment plus follow on (up tp 10m/project) |
Global Health Impact Fund
| Other | BioTech Med Tech | Early stage (Preseed - Seed) | ||
Goodgrower
| Family Office/Private Investor | Med Tech Diagnostics Digital Health Software, Digitalisation | Europe and USA | ||
Greensky Capital | Venture Capital Fund Business Angel | BioTech Med Tech Hightech, Technology Platforms Software, Digitalisation | Canada | Early stage (Preseed - Seed) | |
Hadean Ventures | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Global (focus Scandinavia, DACH) | Early stage (Preseed - Seed)
Later stage (Series A+)
| |
Headline | Venture Capital Fund | Software, Digitalisation | Global | Early stage (Preseed - Seed)
Later stage (Series A+)
Private Equity | 1m-50m |
HealthX Ventures | Venture Capital Fund | Digital Health | Early stage (Preseed - Seed) | 1m-3m | |
Heran Partners BV | Venture Capital Fund | BioTech Digital Software, Digitalisation | |||
High-Tech Gruenderfonds (HTGF) Venture Capital | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Germany | Early stage (Preseed - Seed)
| up to 1m |
IBB Ventures | Venture Capital Fund | BioTech, Therapeutics, Digital Health, Platforms Software, Digitalisation | Berlin | ||
ICG Intermediate capital group | Other | Private Equity | |||
Ignite Capital Partners | Family Office/Private Investor | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation diverse | USA, Canada, Australia | Early stage (Preseed - Seed)
Later stage (Series A+)
Private Equity | |
Illumina Accelerator (UK) | Start-up Accelerator | BioTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | up to 0.2m | ||
Indaco Ventures Partners Bio Fund | Venture Capital Fund | Therapeutics Hightech, Technology Platforms Oncology, CNS, Ophthalmology, Metabolic diseases, Virology and Infectious diseases | Focus Italy (25% outside Italy) | Early stage (Preseed - Seed)
Later stage (Series A+)
| |
Inkef capital | Venture Capital Fund | MedTech Therapeutics Digital Health Software, Digitalisation | |||
Innovationspreis der BioRegionen
| Other | BioTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms prize for patents | Germany | 2k cash prize | |
Inveready | Venture Capital Fund | BioTech Therapeutics Digital Health Hightech, Technology Platforms | Europe | Early stage (Preseed - Seed) Later Stage (Series A+) Private Equity | 0.4m-20m |
Jeito Capital | Venture Capital Fund | BioTech | Global, but focus on Europe | Early stage (Preseed - Seed) Later Stage (Series A+) | |
KIZOO Technology Ventures
| Venture Capital Fund | BioTech Therapeutics rejuvenation biotech | Early stage (Preseed - Seed)
| ||
Karista | Venture Capital Fund | BioTech Med Tech Therapeutics Digital Health | Western Europe | Early stage (Preseed - Seed) Later Stage (Series A+) | 500k-€5m |
Karma Fund | Venture Capital Fund | Digital Health Software, Digitalisation | Europe | Early stage (Preseed - Seed)
Later stage (Series A+)
| up to 5m |
KfW: ERP-Digitalisierungs- und Innovations-kredit | Other | Software, Digitalisation | Germany | loan 25k-25m | |
KfW: ERP-Gruenderkredit StartGeld | Other | Germany | loan up to 125k | ||
KfW: KfW-Unternehmerkredit | Other | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation loan, all sectors, >5 years | Germany | loan up to 100m | |
Kurma Partners | Venture Capital Fund | BioTech Diagnostics Therapeutics | Focus Europe | Early stage (Preseed - Seed)
Later stage (Series A+)
| |
LBBW Venture Capital | Venture Capital Fund | BioTech MedTech Therapeutics Digital Health Software, Digitalisation | DACH | ||
LDC
| Bank Fund | Hightech, Technology Platforms very broad | UK |
Private Equity | |
LifeArc Ventures | Venture Capital Fund | BioTech Med Tech Therapeutics Digital Health Hightech, Technology Platforms | Early stage (Preseed - Seed) Later Stage (Series A+) | ||
LifeLink Ventures | Venture Capital Fund | BioTech Therapeutics focus on Europe | Global | Early stage (Preseed - Seed)
Later stage (Series A+)
| no ticket size restrictions |
Linden Capital Partners
| Corporate Investor (CVC) | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms |
Private Equity | ||
Longe VC | Venture Capital Fund | BioTech Diagnostics Therapeutics Hightech, Technology Platforms Software, Digitalisation longevity focus | Early stage (Preseed - Seed)
| ||
Lundbeckfonden Biocapital | Corporate Investor (CVC) | BioTech MedTech Therapeutics evergreen fund | Early stage (Preseed - Seed)
Later stage (Series A+)
Private Equity | ||
M Ventures | Corporate Investor (CVC) | BioTech MedTech Therapeutics Digital Health Hightech, Technology Platforms | Early stage (Preseed - Seed)
Later stage (Series A+)
| ||
MBG Baden-Wuerttemberg | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Baden-Wuerttemberg | Early stage (Preseed - Seed)
Later stage (Series A+)
| 0.2m - 3m |
MIG Capital | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Early stage (Preseed - Seed)
Later stage (Series A+)
| 1-10m | |
MRL Ventures Fund | Corporate Investor (CVC) | BioTech Therapeutics | Early stage (Preseed - Seed) Later Stage (Series A+) | up to 25m | |
Medi Ventures | Venture Capital Fund | BioTech Diagnostics Therapeutics Hightech, Technology Platforms Software, Digitalisation | Early stage (Preseed - Seed)
| ||
Medicxi Ventures | Venture Capital Fund | BioTech Therapeutics | |||
Merck Research Challenges | Other | BioTech MedTech Diagnostics Digital Health Hightech, Technology Platforms Software, Digitalisation varying topics | Global | 10k cash prize | |
Mission BioCapital | Other | BioTech Therapeutics | Early stage (Preseed - Seed) Later Stage (Series A+) | ||
Mission BioCapital Platinum Program 2023 | Other | Biotech Diagnostics Therapeutics | Early stage (Preseed - Seed) | 500k | |
Molten Ventures | Venture Capital Fund | BioTech Med Tech Hightech, Technology Platforms Software, Digitalisation | UK, Europe | Later Stage (Series A+) | 5m-20m |
Monograph Capital | Venture Capital Fund | BioTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms | |||
NCL Technology Venture | Venture Capital Fund | BioTech Therapeutics Hightech, Technology Platforms | Global, focus UK? | ||
NIXDORF Kapital AG | Family Office/Private Investor | sustainability is important | |||
NLC Ventures | Start-up Accelerator | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms | Europe | initially up to 100k, then up to 9m | |
NRW.Venture | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Focus NRW | Early stage (Preseed - Seed)
Later stage (Series A+)
| up to 15m |
Negma Group | Venture Capital Fund | Early stage (Preseed - Seed) Later Stage (Series A+) Private Equity | |||
New Science Fund | Venture Capital Fund | BioTech Med Tech Therapeutics Digital Health Hightech, Technology Platforms | USA, Europe | Early stage (Preseed - Seed) Later Stage (Series A+) | |
Nextech Ventures | enture Capital Fund | BioTech Therapeutics | USA, Europe
| Early stage (Preseed - Seed) | |
Novartis Venture Fond | Corporate Investor (CVC) | BioTech Therapeutics | Global | Early stage (Preseed - Seed)
| |
Novo Holdings A/S | Corporate Investor (CVC) | BioTech MedTech Therapeutics Digital Health | Global, except very early stage only Scandinavia | Early stage (Preseed - Seed)
Later stage (Series A+)
Private Equity | ca. up to 20m (500m in principal investments) |
Occident | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Germany, Switzerland | Early stage (Preseed - Seed)
Later stage (Series A+)
| >500k |
Omnes Capital | Venture Capital Fund | BioTech Hightech, Technology Platforms Software, Digitalisation | Europe, focus France, DACH | Early stage (Preseed - Seed) Later Stage (Series A+) Private Equity | 2m-7m, with follow-on up to 20m |
PEPPERMINT Venture Partners
| Venture Capital Fund | BioTech MedTech Therapeutics Digital Health Ophtalmic and cardiovascular diseases | Germany | Early stage (Preseed - Seed)
| |
Pace Ventures | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation, climate | EU, US | Early stage (Preseed - Seed) | 500k-1.5m |
Palatina - Business Angels Rhein-Neckar e.V. | Business Angel | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Germany | Early stage (Preseed - Seed)
| |
Panacea Venture | Venture Capital Fund | BioTech Med Tech Diagnostics Therapeutics | China, USA, Europe
| Early stage (Preseed - Seed) Later Stage (Series A+) | |
Panakes partners | Venture Capital Fund | EU, Israel | |||
Plug and Play Ventures | Venture Capital Fund | BioTech Med Tech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Early stage (Preseed - Seed) Later Stage (Series A+) | average 148k | |
Pureos Bioventures | Venture Capital Fund | BioTech Therapeutics | |||
RBV Capital | Venture Capital Fund | BioTech MedTech Therapeutics Digital Health | Global | Early stage (Preseed - Seed)
Later stage (Series A+)
| 1-3m first investment plus follow on (10m/project) |
Redalpine | Venture Capital Fund | MedTech Digital Health Hightech, Technology Platforms Software, Digitalisation | Europe | Early stage (Preseed - Seed) | |
Redcliffe capital | Venture Capital Fund | Early stage (Preseed - Seed) Later Stage (Series A+) | |||
Roche Venture Fund | Corporate Investor (CVC) | BioTech Diagnostics Therapeutics Digital Health | Global | Early stage (Preseed - Seed) Later Stage (Series A+) | 3-10m |
Roivant Sciences GmbH | Other | BioTech Therapeutics Software, Digitalisation | Early stage (Preseed - Seed) Later Stage (Series A+) | ||
Ryse asset management | Venture Capital Fund | Digital Health Hightech, Technology Platforms Software, Digitalisation | Early stage (Preseed - Seed) | ||
SHS Venture | Venture Capital Fund | BioTech MedTech Diagnostics Digital Health | DACH, Benelux, Scandinavia | Early stage (Preseed - Seed)
Later stage (Series A+)
| average 5m |
SV Health Investors | Venture Capital Fund | BioTech Med Tech Therapeutics Software, Digitalisation | Early stage (Preseed - Seed) Later Stage (Series A+) Private Equity | ||
Sanner Ventures | Family Office/Private Investor | MedTech Diagnostics Digital Health Hightech, Technology Platforms Software, Digitalisation | Focus Europe | Early stage (Preseed - Seed)
| |
Sanofi Ventures | Corporate Investor (CVC) | BioTech Therapeutics Digital Health | Early stage (Preseed - Seed) Later Stage (Series A+) Private Equity | ||
Seed+speed the sales VC | Venture Capital Fund | Software, Digitalisation | DACH | Early stage (Preseed - Seed)
| up to 0.5m (first investment) |
Seventure Partners | Venture Capital Fund | BioTech MedTech Therapeutics Digital Health microbiome as a focus | Europe, North America, Asia | Early stage (Preseed - Seed)
Later stage (Series A+)
| 1m-10m |
Seventure Venture
| Venture Capital Fund | BioTech MedTech Digital Health focused on microbiome, foodtech; Separater fund for Animal Health und Sport Tech (Olympia 2024 Paris) | Global | Early stage (Preseed - Seed)
Later stage (Series A+)
| |
Ship2BVentures | Venture Capital Fund | MedTech Digital Health Climate and education | 80% Spain 20% EU | Early stage (Preseed - Seed)
Later stage (Series A+)
| 0.2-2m |
Signals Venture Capital
| Venture Capital Fund | Software, Digitalisation B2B software-centric business models across all enterprise segments | Europe, USA, Israel | Early stage (Preseed - Seed)
Later stage (Series A+)
| 1m-5m |
SixThirty
| Venture Capital Fund | Digital Health Hightech, Technology Platforms fintech, insurtech, privacy, digital health | Global | Early stage (Preseed - Seed)
| |
Sofinnova Partners | Venture Capital Fund | BioTech MedTech Therapeutics Digital Health | Focus Europe | Early stage (Preseed - Seed)
Later stage (Series A+)
| |
Sound Bioventures | -Venture Capital Fund | BioTech Therapeutics | Scandinavia, Europe, USA | Later Stage (Series A+) | |
Speedinvest
| Venture Capital Fund | Digital Health Hightech, Technology Platforms Software, Digitalisation | Europe | Early stage (Preseed - Seed)
| 100k-2m |
Startup Angels Alb-Bodensee e.V. | Business Angel | MedTech Digital Health Hightech, Technology Platforms Software, Digitalisation | Germany | Early stage (Preseed - Seed)
| |
Startup Creasphere (DE) | Start-up Accelerator | Digital Health Software, Digitalisation | Early stage (Preseed - Seed)
| ||
Sunstone Life Science Ventures | Venture Capital Fund | BioTech Therapeutics | Europe | Early stage (Preseed - Seed) Later Stage (Series A+) | |
Super Capital VC | Business Angel | Digital Health Hightech, Technology Platforms Software, Digitalisation | Early stage (Preseed - Seed) | ||
Syncona | Venture Capital Fund | BioTech Therapeutics | UK, Europe | Later Stage (Series A+) | |
TVM Capital Life Science | Venture Capital Fund | BioTech MedTech Therapeutics Digital Health | Global |
Later stage (Series A+)
| |
Taiho Ventures | Corporate Investor (CVC) | BioTech Therapeutics Hightech, Technology Platforms MedTech, Diagnostics, Digital Health only opportunistically | Focus USA, Europe, Japan, China | 10m-20m | |
The Spinoff Prize, a Nature Research Award
| Other | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Global | 30k cash prize | |
Think.Health Ventures | Venture Capital Fund | Therapeutics | Early stage (Preseed - Seed)
| 500k-10m | |
Thuja Capital | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics | Netherlands, Germany, Belgium | 500k-3m up to 10m | |
Trumpf Venture | Corporate Investor (CVC) | MedTech Diagnostics Hightech, Technology Platforms Software, Digitalisation | Early stage (Preseed - Seed)
| 0.5-4m | |
UCB Ventures | Corporate Investor (CVC) | BioTech Therapeutics Digital Health Hightech, Technology Platforms | USA, Europe | Early stage (Preseed - Seed) Later Stage (Series A+) | |
V-Bio Ventures | Venture Capital Fund | BioTech Diagnostics Therapeutics agriculture | Belgium (VIB) 60%, rest focus Europe | Early stage (Preseed - Seed)
Later stage (Series A+)
| |
VI Partners | Venture Capital Fund | BioTech MedTech Therapeutics Hightech, Technology Platforms | Europe | Early stage (Preseed - Seed)
Later stage (Series A+)
| |
VP Ventures Partners | Venture Capital Fund | Therapeutics Digital Health Hightech, Technology Platforms | EU (little focus on DACH region) | Early stage (Preseed - Seed) Later Stage (Series A+) | 250k-750k up to 1m-1.5m |
VR-InnovationsPreis Mittelstand | Other | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation any innovative idea | Baden-Wuerttemberg | 50k cash prize | |
Venionaire Capital | Other | BioTech Med Tech Digital Health Hightech, Technology Platforms Software, Digitalisation | Europe | Later Stage (Series A+) Private Equity | 500k-10m |
Venture Forum Neckar e.V. | Business Angel | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Early stage (Preseed - Seed)
| ||
Verve Ventures | Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms | Europe | Early stage (Preseed - Seed)
Later stage (Series A+)
| 0.5m-5m |
Vespucci Partners | Venture Capital Fund | BioTech Med Tech Diagnostics Digital Health Hightech, Technology Platforms Software, Digitalisation | Central Europe | Early stage (Preseed - Seed) Later Stage (Series A+) | 600k - 4.5m |
Viva BioInnovator | Corporate Investor (CVC) | BioTech Therapeutics | Global | Early stage (Preseed - Seed)
Later stage (Series A+)
| |
Volvér Ventures | Venture Capital Fund | Software, Digitalisation | Focus Denmark, Global | Early stage (Preseed - Seed) | |
Walden Catalyst Ventures | Venture Capital Fund | Digital Health Hightech, Technology Platforms Software, Digitalisation | US, Europe, Israel | Early stage (Preseed - Seed) | |
Wellington Partners
| Venture Capital Fund | BioTech MedTech Diagnostics Therapeutics Digital Health | Focus Europe | Early stage (Preseed - Seed)
Later stage (Series A+)
| 2m-20m |
Wille Finance | Family Office/Private Investor | BioTech MedTech Diagnostics Therapeutics Digital Health Software, Digitalisation | Europe | Early stage (Preseed - Seed)
| 500k-10m |
aescuvest | Other | MedTech Diagnostics Digital Health Hightech, Technology Platforms Software, Digitalisation | EU | 1m-5m | |
btov Partners | Venture Capital Fund | MedTech Digital Health Hightech, Technology Platforms Software, Digitalisation | EU | Early stage (Preseed - Seed)
| 0.25m-10m |
dievini Hopp BioTech holding | Family Office/Private Investor | BioTech Therapeutics | |||
eleven | Venture Capital Fund | Hightech, Technology Platforms Software, Digitalisation | Southeast Europe | Early stage (Preseed - Seed)
| |
fiftyyears | Venture Capital Fund | MedTech Diagnostics Therapeutics Digital Health Hightech, Technology Platforms Software, Digitalisation | Europe, US, Canada | Early stage (Preseed - Seed) | |
iBionext | Venture Capital Fund | BioTech Med Tech Digital Health Software, Digitalisation | Early stage (Preseed - Seed) Later Stage (Series A+) |
bottom of page